JohnBoy2000
Bluelighter
- Joined
- May 11, 2016
- Messages
- 2,468
So - I normally dose Strattera/Atomoxetine in the morning.
I wanted to add in a serotonergic component - so I tried Effexor.
It combined awfully dosed simultaneously with Atomoxetine in the morning - so I tried it at 4 pm - and it was better tolerated.
I can't dose it at night - as it induces insomnia like that.
I dosed it to a max of 75 mg - as that was all I could tolerate.
But ultimately - I had to taper off it as, although I benefited, the long term interaction proved to be negative.
So - Atomoxetine, I dose it high at 80 mg - activating - fantastic restoration of functionality.
I am considering reducing this dose, instead dosing Effexor in the morning to 225 mg - the activating dose - and using Atomoxetine as a "booster" of the noradrenergic effect, as it were.
I have no idea how that will work out.
Is it possible it may be tolerated given the dose increase/decrease, in contrast to the initially poorly tolerated approach?
As to the underlying pharmacology - technically Effexor has a favourable interaction profile but - it didn't work out that way before.
Can anyone lend some kind of insight as to this?
I wanted to add in a serotonergic component - so I tried Effexor.
It combined awfully dosed simultaneously with Atomoxetine in the morning - so I tried it at 4 pm - and it was better tolerated.
I can't dose it at night - as it induces insomnia like that.
I dosed it to a max of 75 mg - as that was all I could tolerate.
But ultimately - I had to taper off it as, although I benefited, the long term interaction proved to be negative.
So - Atomoxetine, I dose it high at 80 mg - activating - fantastic restoration of functionality.
I am considering reducing this dose, instead dosing Effexor in the morning to 225 mg - the activating dose - and using Atomoxetine as a "booster" of the noradrenergic effect, as it were.
I have no idea how that will work out.
Is it possible it may be tolerated given the dose increase/decrease, in contrast to the initially poorly tolerated approach?
As to the underlying pharmacology - technically Effexor has a favourable interaction profile but - it didn't work out that way before.
Can anyone lend some kind of insight as to this?